AzTrials
AzTrials

Cochlear Impant ChildrenNCT06841900

Implementation of the International Classification of Functioning, Disability and Health Model in Paediatric Cochlear Implant Recipients

An observational study of Cochlear Impant Children, run by University Hospital, Antwerp at 6 sites in 6 countries.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to implement the International Classification of Functioning, disability and health (ICF) in paediatric Cochlear Implant (CI) recipients (<18 years) with prelingual sensorineural hearing loss in a multicenter prospective study to evaluate audiological rehabilitation after cochlear… Read more about this study

Who is it for?
Any age
Conditions the study is for
Cochlear Impant Children
What is being tested?
Cochlear Implantation
Type of treatment
Medical device
How many people
120 participants
Where
6 sitesin 6 countries
Study dates
Mar 2025to Mar 2027
How long will I take part?
1 Year
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Paediatric Cochlear Implant (CI) recipients (<18 years) with prelingual sensorineural hearing loss

Who may be able to join

  • General
  • Children aged < 18 years with prelingual bilateral severe-to-profound HL
  • Signed and dated informed consent, informed permission and/or minor's assent.
  • Willingness to participate in evaluations, test sessions, and medical follow-up sessions as defined in the protocol.
  • Physical and mental competence to participate in fitting of the device and follow-up sessions as defined in the protocol.
  • Audiological
Show all 10Show fewer
  • Completion of hearing assessment battery showing suitability of the CI candidates.
  • Compliance with cochlear implant candidate selection criteria of the implanting centre.
  • First cochlear implantation Medical
  • Patent cochlea, as evidenced by High-resolution computed tomography (HRCT) and/or Magnetic Resonance Imaging (MRI).

Who cannot join

  • General
  • Re-implantation of the cochlear implant
  • No motivation to participate in the study and/or unreasonable expectations. Medical
  • Presence of contra-indications for surgery in general and cochlear implantation in particular.
  • Presence of central auditory lesions.
  • Any disorder that may relate to an increased risk of skin flap problems Use of one of the following electrodes for implantation
Show all 9Show fewer
  • Compressed
  • Split
  • Any type of custom made electrodes

Trial locations and contacts

6 sites in 6 countries. Contact the study team or a site near you to ask about taking part.

Ellen Andries, PhD AUD contact

+32 3 275 7372

ellen.andries@uza.be

Griet Mertens, PhD AUD contact

griet.mertens@uza.be

6 sites in 6 countries

Australia1 site
  • Fiona Stanley Fremantle Hospital Group

    Perth

    Dayse Tavora-Viera, +61 8 6488 4880, dayse.tavora@gmail.com

    Aanand Acharya

Other trials in Australia

Belgium1 site
  • University Hospital Antwerp

    Edegem, 2650

    Ellen Andries, +32 3 275 7372, ellen.andries@uza.be

    Griet Mertens, griet.mertens@uza.be

Other trials in Belgium

Germany1 site
  • University Clinic of Würzburg

    Würzburg

    Anja Kurz, +49 - 931 201 21701, Kurz_A@ukw.de

    Anja Kurz

Other trials in Germany

Poland1 site
  • World Hearing Centre

    Warsaw

    Artur Lorens, 954-404-6477, a.lorens@ifps.org.pl

    Artur Lorens

Other trials in Poland

Saudi Arabia1 site
  • King Abdullah Ear Specialist Center (KAESC)

    Riyadh

    Medhat Yousef, +966 1 4670888, myousef@ksu.edu.sa

    Medhat Yousef

Other trials in Saudi Arabia

Spain1 site
  • Hospital La Paz

    Madrid

    Miryam Calvino, +34 917 27 70 00, miryamcf@yahoo.com

    Miryam Calvino

Other trials in Spain

About this study

Official title: Implementation of the International Classification of Functioning, Disability and Health Model in Paediatric Cochlear Implant Recipients: a Multi-center Prospective Follow-up Cohort Study

The aim of this study is to implement the International Classification of Functioning, disability and health (ICF) in paediatric Cochlear Implant (CI) recipients (<18 years) with prelingual sensorineural hearing loss in a multicenter prospective study to evaluate audiological rehabilitation after cochlear implantation. For this, ICF qualifiers which denote the magnitude of the level of health or severity of the problem will be quantified. Outcome measures include four questionnaires and three standard audiological examinations. Subjects will be assessed up to 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor.

Being tested
Cochlear Implantation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cochlear ImplantationDevice

    Standard cochlear implantation

Study groups in NCT06841900
Study groupRoleWhat they receive
Cochlear Implant (CI) recipients (<18 years) with prelingual sensorineural hearing lossCochlear Implant (CI) recipients (<18 years) with prelingual sensorineural hearing loss
Receives: Device: Cochlear Implantation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in LittlEARS® Auditory Questionnaire (LEAQ)

    The LittlEARS® Auditory Questionnaire (LEAQ) was created to aid professionals and caregivers in the assessment of auditory capabilities among infants and toddlers experiencing hearing impairment. Grounded in the observations made by caregivers concerning the auditory responses exhibited by their children in everyday settings, this questionnaire comprises 35 questions tailored to specific age groups, necessitating responses of either 'yes' or 'no'. These questions are designed to capture significant milestones in auditory development during the initial two years of life or within the first two years following the onset of hearing intervention for children utilizing hearing devices. The questionnaire is suitable for children up to 24 months old, or with a hearing age of 24 months.

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

  2. Change in Speech, Spatial and Qualities of Hearing Scale for Parents (SSQ-P)

    The original SSQ was adapted for use in children, resulting in the development of the SSQ-P. Each of the 23 items in the questionnaire presents a scenario followed by a question regarding the child's hearing ability within that scenario. These items are categorized into three dimensions: speech perception, spatial hearing, and qualities of hearing. Parents are tasked with providing a rating between 0 and 10 for each item, where 0 signifies that the child could not perform in the scenario at all and 10 indicates perfect performance. Additionally, parents are asked to indicate how frequently the scenario would occur and to rate the importance of the listening skills required for that scenario.

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

  3. Change in Speech Intelligibility Rating (SIR)

    The Speech Intelligibility Rating (SIR) comprises spoken passages, wherein the degree of intelligibility is evaluated using an interval scale spanning from 0 to 10, ensuring uniformity in rating perception. The SIR assessment uses 20 standardized passages delivered by a single speaker, each identified as possessing comparable levels of intelligibility. The SIR is typically used in children with hearing loss from around the age of 2 years old .

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

  4. Parent's Evaluation of Aural/Oral Performance of Children (PEACH)

    The PEACH is a 13-item questionnaire designed for parental assessment of a 3- to 7-year-old child's aural and oral abilities in everyday life. The PEACH asks parents to consider their child's listening behaviors over the past week and then assigns a numerical value to the answers ranging from 0 (Never or 0 %) to 4 (Always or 75 to 100 %). The PEACH questions assess listening behaviors in both quiet and noisy surroundings.

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

  5. Standard pure tone audiometry, Behavioral Observation Audiometry (BOA), Visual Reinforcement Audiometry (VRA) or Play Audiometry

    Standard pure tone audiometry, Behavioral Observation Audiometry (BOA), Visual Reinforcement Audiometry (VRA) or Play Audiometry will be performed according to current clinical standards (ISO 8253-1, 2010), depending on the age of the participant. Pre- and postoperatively, best-aided audiometry will be measured at 250, 500, 1000, 2000, 4000 and 8000 Hz using warble tones in sound field in a sound treated booth. The loudspeaker will be placed in front of the participant at ear level at 1 meter distance. The best-aided pure tone average (PTA4, primary outcome measurement) will be calculated by averaging participants' hearing thresholds at 500, 1000, 2000 and 4000 Hz in best-aided condition.

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

  6. Auditory Brainstem Response (ABR) Audiometry

    ABR audiometry involves the generation of an evoked potential through a brief auditory stimulus (e.g., click, chirp, etc.) transmitted via an acoustic transducer (insert earphone or headphone). The resulting waveform response is detected by surface electrodes positioned at the vertex of the scalp and ear lobes. The signal's amplitude is averaged and plotted against time and waveform peaks are identified as I-VII. These waveforms typically occur within a 10-millisecond window following a click stimulus presented at high intensities (70-90 dB normal hearing level [nHL]). ABR audiometry is suitable for children of all ages.

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

  7. Ling Sounds (detection/discrimination)

    For Ling sound detection, the participants' detection of six sounds (oo, ah, ee, mm, sh, ss) will be observed in a variety of game formats. In the clinic, each sound is presented six times without lipreading, and the child simply responds. Score "S" will be given if the skill is emerging, score "A" will be given if the child has been observed to carry out the tasks consistently. For Ling discrimination, the phoneme "ee" will be repeated and all six Ling Sounds will be randomly inserted. Score "S" will be given if the child is consistently able to discriminate any one sound out of the six, score "A" will be given if the child is consistently able to discriminate all six sounds. The Ling test is suitable for children from approximately 6 months of age to adulthood.

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

Secondary outcomes (1)
  1. Subject Demographics

    Subject demographics will be retrieved from the participants' medical file or by asking the parents if the information is not available. The 11th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11) classification will be used to code subjects' health conditions.

    Measured: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2025
  2. Study startMar 2025 (estimated)
  3. Primary completionMar 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT06841900
Sponsor's protocol ID
ICF in Paediatric CI users
Status last verified
Feb 2025
First submitted
17 Feb 2025
Last updated
28 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cochlear Impant Children, run by University Hospital, Antwerp at 6 sites in 6 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Australia, Belgium, Germany, Poland, Saudi Arabia and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ellen Andries, PhD AUD (+32 3 275 7372, ellen.andries@uza.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in LittlEARS® Auditory Questionnaire (LEAQ) (time frame: 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in